Search Results
Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Search for other papers by Ali S Alzahrani in
Google Scholar
PubMed
Search for other papers by Meshael Alswailem in
Google Scholar
PubMed
Département de Médecine Génomique des Tumeurs et des Cancers, Fédération de Génétique et de Médecine Génomique, Assistance Publique-Hôpitaux de Paris (AP-HP) Centre, Hôpital Européen Georges Pompidou, Paris, France
Search for other papers by Alexandre Buffet in
Google Scholar
PubMed
Search for other papers by Balgees Alghamdi in
Google Scholar
PubMed
Search for other papers by Lulu Alobaid in
Google Scholar
PubMed
Search for other papers by Osamah Alsagheir in
Google Scholar
PubMed
Search for other papers by Hindi Al-Hindi in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Introduction Pheochromocytomas (PCCs) and paragangliomas (PGLs, abbreviated together as PPGLs) are rare neuroendocrine tumors of the adrenal medulla and the peripheral autonomic ganglia, respectively ( Lenders 2014 ). They arise from
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
delays caused by the COVID-19 pandemic. In the intervening years, two international meetings related to pheochromocytomas (PCC) and paragangliomas (PGL) took place, Multiple Endocrine Neoplasia Workshop 2019 (in Houston) and 2021 (virtual). In 2019, the
Search for other papers by Katherine I Wolf in
Google Scholar
PubMed
Search for other papers by Linda Rose-Krasnor in
Google Scholar
PubMed
Search for other papers by Stephanie Alband in
Google Scholar
PubMed
Search for other papers by Jacques W M Lenders in
Google Scholar
PubMed
Search for other papers by Lauren Fishbein in
Google Scholar
PubMed
Introduction Pheochromocytomas and paragangliomas (PPGLs) are rare chromaffin-cell tumors from the adrenal medulla and the sympathetic paravertebral ganglia of the thorax, abdomen, and pelvis, as well as along the parasympathetic ganglia at
Search for other papers by Margo Dona in
Google Scholar
PubMed
Search for other papers by Selma Waaijers in
Google Scholar
PubMed
Search for other papers by Susan Richter in
Google Scholar
PubMed
Department of Medicine ΙΙΙ, University Hospital Dresden, Dresden, Germany
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Search for other papers by Jeroen Korving in
Google Scholar
PubMed
Search for other papers by Sarah M Kamel in
Google Scholar
PubMed
Division of Heart and Lungs, Department of Medical Physiology, UMC Utrecht, Utrecht, the Netherlands
Search for other papers by Jeroen Bakkers in
Google Scholar
PubMed
Search for other papers by Elena Rapizzi in
Google Scholar
PubMed
Search for other papers by Richard J Rodenburg in
Google Scholar
PubMed
Search for other papers by Jan Zethof in
Google Scholar
PubMed
Search for other papers by Marnix Gorissen in
Google Scholar
PubMed
Search for other papers by Gert Flik in
Google Scholar
PubMed
Search for other papers by Peter M T Deen in
Google Scholar
PubMed
Search for other papers by Henri J L M Timmers in
Google Scholar
PubMed
of a heterozygous SDH mutation are at risk of developing pheochromocytomas and paragangliomas (PPGLs), although usually a second hit in the form of a somatic mutation in the unaffected SDHB allele is required for the development of PPGLs. PPGLs
Search for other papers by Samuel M O'Toole in
Google Scholar
PubMed
Search for other papers by Judit Dénes in
Google Scholar
PubMed
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Constantine A Stratakis in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Introduction Pituitary adenomas (PA) and phaeochromocytomas/paragangliomas (phaeo/PGL) are relatively rare tumours. The prevalence of symptomatic PA in the general population is around 1 in 1000 ( Daly et al . 2006 , Fernandez et al . 2010 ). The
Search for other papers by Douglas Wiseman in
Google Scholar
PubMed
Search for other papers by James D McDonald in
Google Scholar
PubMed
Search for other papers by Dhaval Patel in
Google Scholar
PubMed
Search for other papers by Electron Kebebew in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Search for other papers by Naris Nilubol in
Google Scholar
PubMed
Introduction Pheochromocytomas and paragangliomas (PPGLs) are rare, catecholamine-secreting tumors arising from the chromaffin cells of the adrenal medulla and extra-adrenal neural crest tissues, which run from the skull base to the pelvis
Search for other papers by Diana E Benn in
Google Scholar
PubMed
Search for other papers by Bruce G Robinson in
Google Scholar
PubMed
Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Introduction Phaeochromocytomas (PCs) are tumours in the adrenal medulla, and paragangliomas (PGLs) arise in extra-adrenal sympathetic chromaffin tissue or head and neck parasympathetic tissues. Familial occurrence of PGLs was first reported in 1933
Search for other papers by Camilo Jimenez in
Google Scholar
PubMed
Search for other papers by Bennett B Chin in
Google Scholar
PubMed
Search for other papers by Richard B Noto in
Google Scholar
PubMed
Search for other papers by Joseph S Dillon in
Google Scholar
PubMed
Search for other papers by Lilja Solnes in
Google Scholar
PubMed
Search for other papers by Nancy Stambler in
Google Scholar
PubMed
Search for other papers by Vincent A DiPippo in
Google Scholar
PubMed
Search for other papers by Daniel A Pryma in
Google Scholar
PubMed
Introduction Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors derived from chromaffin cells of the adrenal medulla and paraganglia, respectively ( Jimenez 2018 ). Each year, approximately 500–1600 new cases of PPGLs
Search for other papers by Arthur Varoquaux in
Google Scholar
PubMed
Search for other papers by Yann le Fur in
Google Scholar
PubMed
Department of Medical Imaging, CNRS, Department of Biophysics and Nuclear Medicine, ICube, Department of Otorhinolaryngology–Head and Neck Surgery, Department of Otorhinolaryngology–Head and Neck Surgery, Program in Reproductive and Adult Endocrinology, Department of Nuclear Medicine, Biophysics and Nuclear Medicine, INSERM, La Timone University Hospital, Aix‐Marseille University, Marseille, France
Search for other papers by Alessio Imperiale in
Google Scholar
PubMed
Search for other papers by Antony Reyre in
Google Scholar
PubMed
Search for other papers by Marion Montava in
Google Scholar
PubMed
Search for other papers by Nicolas Fakhry in
Google Scholar
PubMed
Department of Medical Imaging, CNRS, Department of Biophysics and Nuclear Medicine, ICube, Department of Otorhinolaryngology–Head and Neck Surgery, Department of Otorhinolaryngology–Head and Neck Surgery, Program in Reproductive and Adult Endocrinology, Department of Nuclear Medicine, Biophysics and Nuclear Medicine, INSERM, La Timone University Hospital, Aix‐Marseille University, Marseille, France
Search for other papers by Izzie-Jacques Namer in
Google Scholar
PubMed
Search for other papers by Guy Moulin in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Department of Medical Imaging, CNRS, Department of Biophysics and Nuclear Medicine, ICube, Department of Otorhinolaryngology–Head and Neck Surgery, Department of Otorhinolaryngology–Head and Neck Surgery, Program in Reproductive and Adult Endocrinology, Department of Nuclear Medicine, Biophysics and Nuclear Medicine, INSERM, La Timone University Hospital, Aix‐Marseille University, Marseille, France
Search for other papers by Maxime Guye in
Google Scholar
PubMed
Department of Medical Imaging, CNRS, Department of Biophysics and Nuclear Medicine, ICube, Department of Otorhinolaryngology–Head and Neck Surgery, Department of Otorhinolaryngology–Head and Neck Surgery, Program in Reproductive and Adult Endocrinology, Department of Nuclear Medicine, Biophysics and Nuclear Medicine, INSERM, La Timone University Hospital, Aix‐Marseille University, Marseille, France
Department of Medical Imaging, CNRS, Department of Biophysics and Nuclear Medicine, ICube, Department of Otorhinolaryngology–Head and Neck Surgery, Department of Otorhinolaryngology–Head and Neck Surgery, Program in Reproductive and Adult Endocrinology, Department of Nuclear Medicine, Biophysics and Nuclear Medicine, INSERM, La Timone University Hospital, Aix‐Marseille University, Marseille, France
Search for other papers by David Taïeb in
Google Scholar
PubMed
Introduction Paragangliomas (PGLs) are slow-growing hypervascular tumors arising from neural crest cell derivatives throughout the body. PGLs are closely aligned with the distribution of the autonomic nervous system and preferentially arise in the
Search for other papers by Liang Zhang in
Google Scholar
PubMed
Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Search for other papers by Joakim Crona in
Google Scholar
PubMed
Introduction Pheochromocytomas (PCCs) and paragangliomas (PGLs, together denoted as PPGLs) are rare endocrine tumors originating from chromaffin cells in the adrenal medulla (PCC) and extra-adrenal paraganglia (PGL). Sympathetic PPGLs secrete